Vanda Pharmaceuticals (NASDAQ:VNDA) has experienced a significant shift in its stock rating, moving from a “strong-buy” to a “hold” designation according to research conducted by Zacks...
Equities research firm Zacks Research recently downgraded Rhythm Pharmaceuticals (NASDAQ:RYTM) from a “hold” rating to a “strong sell” rating. This decision was outlined in a research...
Rhythm Pharmaceuticals (NASDAQ: RYTM) faced a significant downgrade from Zacks Research, moving from a “hold” rating to a “strong sell” rating, as reported on Monday. This...
Healthcare Services Group (NASDAQ:HCSG) received a downgrade from a “strong-buy” to a “buy” rating by analysts at Wall Street Zen, according to a note released to...
CICC Research has initiated coverage of Take-Two Interactive Software (NASDAQ: TTWO) with an **outperform** rating and a target price of **$272.00**. This announcement, made in a...
Research analysts at Mizuho have initiated coverage on shares of Primoris Services (NASDAQ: PRIM), assigning the construction company a “neutral” rating along with a price target...
Research analysts from Mizuho have initiated coverage on shares of Primoris Services (NASDAQ:PRIM), issuing a report on Thursday that assigns a “neutral” rating along with a...
Shares of Molson Coors Beverage Company (NYSE:TAP) have garnered a consensus recommendation of “Hold” from a network of sixteen research firms, according to data from MarketBeat...
